staurosporine aglycone has been researched along with Osteosarcoma in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chipoy, C | 1 |
| Brounais, B | 1 |
| Trichet, V | 1 |
| Battaglia, S | 1 |
| Berreur, M | 1 |
| Oliver, L | 1 |
| Juin, P | 1 |
| Rédini, F | 1 |
| Heymann, D | 1 |
| Blanchard, F | 1 |
1 other study available for staurosporine aglycone and Osteosarcoma
| Article | Year |
|---|---|
Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53.
Topics: Apoptosis; bcl-2-Associated X Protein; Carbazoles; Caspases; Cell Line; Cell Line, Tumor; Cell Proli | 2007 |